ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves New Study to Seek Causes Of Rising Breast Cancer Incidence In Young Women

May 27, 1988

New Drug Reverses Damage To Liver In Stem Cell Transplant

September 27, 2002

NCAB Calls For Modification Of Rules For NIH Scientist-Industry Collaboration

December 10, 2010

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

Jane Henney Said Tentative Choice For FDA Commissioner

May 22, 1998

Cancer Act Impact; Mortality Decline; DeVita Tells ACCC

October 9, 1992